Natures Sunshine Products Inc
$ 27.34
4.03%
17 Apr - close price
- Market Cap 478,658,000 USD
- Current Price $ 27.34
- High / Low $ 27.50 / 26.49
- Stock P/E 25.79
- Book Value 9.23
- EPS 1.06
- Next Earning Report 2026-05-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.06 %
- ROE 0.13 %
- 52 Week High 28.14
- 52 Week Low 11.15
About
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company is headquartered in Lehi, Utah.
Analyst Target Price
$33.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-18 | 2025-11-06 | 2025-07-31 | 2025-05-05 | 2025-03-10 | 2024-11-07 | 2024-08-08 | 2024-05-07 | 2024-03-12 | 2023-11-07 | 2023-08-09 | 2023-05-09 |
| Reported EPS | 0.3 | 0.36 | 0.28 | 0.25 | -0.0174 | 0.23 | 0.07 | 0.12 | 0.45 | 0.15 | 0.12 | 0.23 |
| Estimated EPS | 0.2079 | 0.18 | 0.17 | 0.165 | 0.2 | 0.14 | 0.25 | 0.17 | 0.15 | 0.14 | 0.03 | -0.01 |
| Surprise | 0.0921 | 0.18 | 0.11 | 0.085 | -0.2174 | 0.09 | -0.18 | -0.05 | 0.3 | 0.01 | 0.09 | 0.24 |
| Surprise Percentage | 44.3001% | 100% | 64.7059% | 51.5152% | -108.7% | 64.2857% | -72% | -29.4118% | 200% | 7.1429% | 300% | 2400% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $1.0 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NATR
2026-04-15 11:11:12
This article identifies "undiscovered gems" in the US market for April 2026, highlighting companies with strong fundamentals and growth potential. It features a list of top 10 companies, including Nature's Sunshine Products, Xunlei, and Central Pacific Financial, providing an overview of their operations, financial performance, and strategic initiatives. The market has seen significant growth, and these selections aim to offer promising investment opportunities.
2026-04-09 04:39:33
Nature's Sunshine Products Inc (NATR) generates most of its revenue from the General Health segment, contributing 41.3% or $47.38M of total sales, followed by Digestive and Cardiovascular segments. The company demonstrates strong profitability with a gross margin of 72.52%, an operating margin of 4.30%, and a net margin of 3.65%, alongside a 12.32% Return on Equity. NATR, with a market capitalization of $462.55M, outperforms competitors like NAGE in gross margin but trails USNA.
2026-03-30 01:39:52
This article reports that the price target for Nature's Sunshine Products (NATR) has been increased by 46.67%, raising it to 33.66. No further details are provided in the current content.
2026-03-28 01:10:11
This article reports a significant increase in the price target for Nature's Sunshine Products (NATR). The target has been raised by 46.67% to $33.66. No further details about the reasons for this increase or who issued it are provided in the snippet.
2026-03-27 21:09:19
Nature's Sunshine Products, Inc. (NATR) has released details for its 2026 annual meeting shareholders will vote on electing eight directors, an advisory "say-on-pay" resolution for executive compensation, ratifying Deloitte & Touche as the independent auditor, and approving a new 2026 Stock Incentive Plan. The company reported net sales of $480.1 million in 2025 (up 2.7%) and net income of $20.5 million, emphasizing a pay-for-performance executive compensation structure tied to adjusted EBITDA growth and relative total shareholder return. The board is majority independent, with separate Chair and CEO roles, and fully independent Audit and Compensation Committees overseeing financial processes, executive pay, and corporate governance.
2026-03-26 18:39:21
Natures Sunshine Products (NATR) rescinded a grant of 29,928 restricted stock units (RSUs) to CEO Kenneth G. Romanzi. The RSUs were initially granted on March 6, 2026, and were intended to vest in three annual installments through March 6, 2029. However, the company cancelled the entire grant on March 24, 2026, before any units had vested, leaving Romanzi with 102,881 common shares.
